Ann: IMUGENE LICENSES CAR T DIRECTED OV THERAPY FOR SOLID TUMOURS, page-274

You said, "I am really looking forward to the upcoming CF33 Phase I clinical trials and its results."

You are not the only one. Leslie Chong in her many interviews, including the latest one with Alan Kohler has been saying the same. She has been hammering the fact that although PH1 is primarily looking for safety, tolerability and safety, but if there is even any hint of efficacy, then this is going to be huge. And she ain't just talking about it. She has put in more than $600K of her own hard earned on it!

So, the day the FDA IND is approved, there will be a rumble, a forewarning, of a big oncology earth shattering news to come. And it could all happen within this year 2021.

Truly exciting time to come for holders.

EDIT: Sorry, the above is meant to reply to @Agent-86. Accidently clicked reply to ricky instead